IMGN News and Press, ImmunoGen Inc. From 12/01/21

Gainers: Arbutus Biopharma (NASDAQ:ABUS) +47%. Ardelyx (NASDAQ:ARDX) +31%. Context Therapeutics (NASDAQ:CNTX) +19%. ImmunoGen (NASDAQ:IMGN) +17%. Skylight Health Group (NASDAQ:SLHG) +16%. Losers: BeyondSpring (NASDAQ:BYSI) -53%. Aditxt (NASDAQ:ADTX) -25%. CTI (NASDAQ:CTIC)...

On Tuesday, ImmunoGen Inc. ( NASDAQ:IMGN ) shares surged by nearly 30% after reporting positive mirvetuximab data in ovarian cancer. The company announced positive top-line data from the SORAYA trial, which measured the safety and efficacy of mirvetuximab soravtansine. However, ...

Omicron and the Federal Reserve combined to send stocks reeling on Tuesday, with the S&P dropping by nearly 2%. Department store chains exemplified the slide, with the added catalyst of a Sell rating for one of the industry's biggest players. Dillard's (NYSE:DDS) lost nearly a fifth of it...

Shares of ImmunoGen (NASDAQ: IMGN) surged 30% on Tuesday after the biotech announced promising clinical trial results for its experimental ovarian cancer therapy, mirvetuximab. The trial was designed to assess the safety and efficacy of mirvetuximab in patients with a form o...

ImmunoGen (NASDAQ:IMGN) has lost ~6.0% in the post-market after the company announced an underwritten public offering of $175M worth of shares of its common stock. A 30-day option is also under consideration to allow underwriters to purchase an additional 15% of the shares of the co...

3 Penny Stocks For Your Watchlist Today With the stock market down today, many investors are looking for penny stocks that could have potential. And to understand which penny stocks would be on that list, we have to first consider why the stock market is down in the first place. Bef...

The stock market saw its recent volatility continue on Tuesday morning, as ongoing concerns about longer-term impacts of new COVID-19 variants weighed on market sentiment. As of 11:30 a.m. ET, the Nasdaq Composite (NASDAQINDEX: ^IXIC) had given up early gains and was down 204 points...

Gainers: Cumberland Pharmaceuticals (NASDAQ:CPIX) +134%. GBS (NASDAQ:GBS) +43%. ImmunoGen (NASDAQ:IMGN) +31%. RenovoRx (NASDAQ:RNXT) +30%. Adagio (NASDAQ:ADGI) +25%. Losers: Triumph Group (NYSE:TGI) -14%. Recruiter (NASDAQ:RCRT) -12%. Hexcel (NYSE:HXL) -10%. United Airlines (NASDAQ:UAL) -10%....

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We’re starting off Tuesday with a breakdown of the biggest pre-market stock movers! Source: f11photo/Shutterstock.com News from the FDA, earnings reports, Omicron concerns, and more ar...

ImmunoGen (NASDAQ:IMGN) soars 32.6% premarket after announcing positive top-line data from the SORAYA trial evaluating the safety and efficacy of mirvetuximab soravtansine (mirvetuximab) monotherapy in patients with folate receptor alpha (FRα)-high platinum-resistant ovarian ...